Differential Induction of DNA-Binding Activities Following CD19 Cross-Linking in Human B Lineage Cells

Journal of Immunology

Volumn 159, Issue 11, 1997, Pages 5502-5508

  Weng, Wen Kai ^a,b   Shah, Nisha ^a   O'Brien, Darin ^a,c   Van Ness, Brian ^a   LeBien, Tucker W ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^c ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD19 ANTIGEN; DNA BINDING PROTEIN; ELK1 PROTEIN, HUMAN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; ONCOPROTEIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR AP 1; TRANSCRIPTION FACTOR ELK 1;

ARTICLE; B LYMPHOCYTE; CELL CULTURE; HUMAN; METABOLISM; PHOSPHORYLATION;

ANTIGENS, CD19; B-LYMPHOCYTES; DNA-BINDING PROTEINS; ETS-DOMAIN PROTEIN ELK-1; HUMANS; NF-KAPPA B; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS; TRANSCRIPTION FACTOR AP-1; TRANSCRIPTION FACTORS; TUMOR CELLS, CULTURED;

EID: 0031307605     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (56)

1. Nadler, L. M., K. C. Anderson, G. Marti, M. Bates, E. Park, J. F. Daley, and S. F. Schlossman. 1983. B4, a human B lymphocyte-associated antigen expressed on normal, mitogen-activated, and malignant B lymphocytes. J. Immunol. 131: 244.
2. Uckun, F. M., W. Jaszcz, J. L. Ambras, A. S. Fauci, K. Gajl-Peczalska, C. W. Song, M. R. Wick, D. E. Myers, K. Waddick, and J. A. Ledbetter. 1988. Detailed studies on expression and function of CD19 surface determinant by using B43 monoclonal antibody and the clinical potential of anti-CD19 immunotoxins. Blood 71:13.
3. Tedder, T. F., and C. M. Isaacs. 1989. Isolation of cDNAs encoding the CD19 antigen of human and mouse B lymphocytes: a new member of the immunoglobulin superfamily. J. Immunol. 143:712.
4. Zhou, L.-J., D. C. Ord, A. L. Hughes, and T. F. Tedder. 1991. Structure and domain organization of the CD19 antigen of human, mouse and guinea pig B lymphocytes: conservation of the extensive cytoplasmic domain. J. Immunol. 147:1424.
5. Songyang, Z., S. E. Shoelson, M. Chaudhuri, G. Gish, T. Pawson, W. G. Haser, F. King, T. Roberts, S. Ratnofsky, R. J. Lechleider, B. G. Neel, R. B. Birge, J. E. Fajardo, M. M. Chou, H. Hanafusa, B. Schaffhausen, and L. C. Cantley. 1993. SH2 domains recognize specific phosphopeptide sequences. Cell 72:767.
6. Songyang, Z., S. E. Shoelson, J. McGlade, P. Olivier, T. Pawson, X. R. Bustelo, M. Barbacid, H. Sabe, H. Hanafusa, T. Yi, R. Ren, D. Baltimore, S. Ratnofsky, R. A. Feldman, and L. C. Cantley. 1994. Specific motifs recognized by the SH2 domains of Csk, 3BP2, fps/fes, GRB-2, HCP, SHC, Syk, and Vav. Mol. Cell. Biol. 14:2777.
7. van Noesel, C. J. M., A. C. Lenkester, and R. A. W. van Lier. 1993. Dual antigen recognition by B cells. Immunol. Today 14:8.
8. Pezzutto, A., B. Dorken, P. S. Rabinovitch, J. A. Ledbetter, G. Moldenhauer, and E. A. Clark. 1987. CD19 monoclonal antibody HD37 inhibits anti-immunoglobulin-induced B-cell activation and proliferation. J. Immunol. 138: 2793.
9. de Rie, M. A., T. N. M. Schumacher, G. M. W. van Schyndel, R. A. W. van Lier, and F. Miedema. 1989. Regulatory role of CD19 molecules in B cell activation and differentiation. Cell. Immunol. 118:368.
10. Barrett, T. B., G. L. Shu, K. E. Draves, A. Pezzutto, and E. A. Clark. 1990. Signaling through CD19, Fc receptor or transforming growth factor-β: each inhibits the activation of resting human B cells differently. Eur. J. Immunol. 20: 1053.
11. Uckun, F. M., and J. A. Ledbetter. 1988. Immunobiological differences between normal and leukemic human B-cell precursors. Proc. Natl. Acad. Sci. USA 85: 8603.
12. Callard, R. E., K. P. Rigley, S. H. Smith, S. Thurstan, and J. G. Shield. 1992. CD19 regulation of human B cell responses. B cell proliferation and antibody secretion are inhibited or enhanced by ligation of the CD 19 surface glycoprotein depending on the stimulating signal used. J. Immunol. 148:2983.
13. Carter, R. H., and D. T. Fearon. 1992. CD19: lowering the threshold for antigen receptor stimulation of B lymphocytes. Science 256:105.
14. Rickert, R. C., K. Rajewsky, and J. Roes. 1995. Impairment of T-cell dependent B-cell responses and B-1 cell development in CD19-deficient mice. Nature 376: 352.
15. Engel, P., L.-J. Zhou, D. C. Ord, S. Sato, B, Koller, and T. F. Tedder. 1995. Abnormal B lymphocyte development, activation, and differentiation in mice that lack or overexpress the CD19 signal transduction molecule. Immunity 3:39.
16. Carter, R. H., D. A. Tuveson, D. J. Park, S. G. Rhee, and D. T. Fearon. 1991. The CD19 complex of B lymphocytes: activation of phospholipase C by a protein tyrosine kinase-dependent pathway that can be enhanced by the membrane IgM complex. J. Immunol. 147:3663.
17. van Noesel, C. J. M., A. C. Lankester, G. M. W. van Schijndel, and R. A. W. van Lier. 1993. The CR2/CD19 complex on human B cells contains the ire-family kinase Lyn. Int. Immunol. 5:699.
18. Roifman, C. M., and S. Ke. 1993. CD19 is a substrate of the antigen receptor-associated protein tyrosine kinase in human B cells. Biochem. Biophys. Res. Commun. 194:222.
19. Chalupny, N. J., A. Aruffo, J. M. Esselstyn, P.-Y. Chan, J. Bajorath. J. Blake, L. K. Gilliland, J. A. Ledbetter, and M. A. Tepper. 1995. Specific binding of Fyn and phosphatidylinositol 3-kinase to the B cell glycoprotein CD19 through their src homology 2 domain. Eur. J. Immunol. 25:2978.
20. Chalupny, M. J., S. B. Kanner, G. L. Schieven, S. Wee, L. K. Gilliland, A. Aruffo, and J. A. Ledbetter. 1993. Tyrosine phosphorylation of CD19 in pre-B and mature B cells. EMBO J. 12:2691.
21. Uckun, F. M., A. L. Burkhardt, L. Jarvis, X. Jun, B. Stealey, I. Dibirdik, D. E. Tuel-Ahlgren, and J. B. Bolen. 1993. Signal transduction through the CD19 receptor during discrete developmental stages of human B-cell ontogeny. J. Biol. Chem. 268:21172.
22. Carter, R. H., G. M. Doody, J. B. Bolen, and D. T. Fearon. 1997. Membrane IgM-induced tyrosine phosphorylation of CD19 requires a CD19 domain that mediates association with components of the B cell antigen receptor complex. J. Immunol. 158:3062.
23. Tuveson, D. A., R. H. Carter, S. P. Soltoff, and D. T. Fearon. 1993. CD19 of B cells as a surrogate kinase insert region to bind phosphatidylinosilol 3-kinase. Science 260:986.
24. Weng, W.-K., L. Jarvis, and T. W. LeBien. 1994. Signaling through CD19 activates Vav/mitogen-activated protein kinase pathway and induces formation of a CD19/Vav/phosphatidylinositol 3-kinase complex in human B cell precursors. J. Biol. Chem. 269:32514.
25. Wormann, B., J. M. Anderson, J. A. Liberty, K. Gajl-Peczalska, R. D. Brunning, T. L. Silberman, D. C. Arthur, and T. W. LeBien. 1989. Establishment of a leukemic cell model for studying human pre-B to B cell differentiation. J. Immunol. 142:110.
26. Martin, D., R. Huang, T. LeBien, and B. Van Ness. 1991. Induced rearrangement of κ genes in the BLIN-1 human pre-B cell line correlates with germline J-Cκ and Jκ transcription. J. Exp. Med. 173:639.
27. Schanke, J. T., A. Marcuzzi, R. P. Podzorske, and B. Van Ness. 1994. An AP1 binding site upstream of the kappa immunoglobulin intron enhancer binds inducible factors and contributes to expression. Nucleic Acids Res. 22:5425.
28. Nelms, K., R. Uromas, and B. Van Ness. 1990. Identification of a second inducible DNA-protein interaction in the kappa immunoglobulin enhancer. Nucleic Acids Res. 18:1037.
29. Zinck, R., M. A. Cahill, M. Kracht, C. Sachsenmaier, R. A. Hipskind, and A. Nordheim. 1995. Protein synthesis inhibitors reveal differential regulation of mitogen-activated protein kinase and stress-activated protein kinase pathways that converge on Elk-1. Mol. Cell. Biol. 15:4930.
30. Jarvis, L. J., J. E. Maguire, and T. W. LeBien. 1997. Contact between human bone marrow stromal cells and B lymphocytes enhances adhesion-independent tyrosine phosphorylation of focal adhesion kinase, paxillin, and ERK-2 in stromal cells. Blood. 90:1626.
31. Gille, H., A. D. Sharrocks, and P. E. Shaw. 1992. Phosphorylation of transcription factor p62TCF by MAP kinase stimulates ternary complex formation at c-fos promoter. Nature 358:414.
32. Cavigelli, M., F. Dolfi, F.-X. Claret, and M. Karin. 1995. Induction of c-fos expression through JNK-mediated TCF/Elk-1 phosphorylation. EMBO J. 14:5957.
33. Whitmarsh, A. J., P. Shore, A. D. Sharrocks, and R. J. Davis. 1995. Integration of MAP kinase signal transduction pathways at the serum response element. Science 269:403.
34. Raingeaud, J., A. J. Whitmarsh, T. Barrett, B. Derijard, and R. J. Davis. 1996. MKK3- and MKK6-regulated gene expression is mediated by the p38 mitogen-activated signal transduction pathway. Mol. Cell. Biol. 16:1247.
35. Hipskind, R. A., V. N. Rao, C. G. Mueller, E. S. Reddy, and A. Nordheim. 1991. Ets-related protein Elk-1 is homologous to the c-fos regulatory factor p62TCF. Nature 354:531.
36. Angel, P., and M. Karin. 1991. The role of Jun, Fos, and the AP-1 complex in cell proliferation and transformation. Biochim. Biophys. Acta 107:129.
37. Baeuerle, P. A., and T. Henkel. 1994. Function and activation of NF-κB in the immune system. Annu. Rev. Immunol. 12:141.
38. Tedder, T. F., L.-J. Zhou, and P. Engel. 1994. The CD19/CD21 signal transduction complex of B lymphocytes. Immunol. Today 15:437.
39. Fearon, D. T., and R. H. Carter. 1995. The CD19/CR2/TAPA-1 complex of B lymphocytes: linking natural to acquired immunity. Annu. Rev. Immunol. 13:127.
40. Li, X., D. Sandoval, L. Freeberg, and R. H. Carter. 1997. Role of CD19 tyrosine 391 in synergistic activation of B lymphocytes by coligation of CD19 and membrane Ig. J. Immunol. 158:5649.
41. Crespo, P., K. E. Schuebel, A. A. Ostrom, J. S. Gutkind, and X. R. Bustelo. 1997. Phosphotyrosine-dependent activation of Rac-1 GDP/GTP exchange by the vav proto-oncogene product. Nature 385:169.
42. Hill, C. S., and R. Treisman. 1995. Transcriptional regulation by extracellular signals: mechanisms and specificity. Cell 80:199.
43. Vogt, P. K., and T. J. Bos. 1990. jun: oncogene and transcription factor. Adv. Cancer Res. 55:1.
44. Deng, T., and M. Karin. 1993. JunB differs from c-Jun in its DNA-binding and dimerization domains, and repress c-Jun by formation of inactive heterodimers. Genes Dev. 7:479.
45. Suzuki, T., H. Okuno, T. Yoshida, T. Endo, H. Nishina, and H. Iba. 1991. Difference in transcriptional regulatory function between c-Fos and Fra-2. Nucleic Acids Res. 19:5537.
46. Hirai, S.-I., R.-P. Ryseck, F. Mechta, R. Bravo, and M. Yaniv. 1989. Characterization of junD: a new member of the jun proto-oncogene family. EMBO J. 8:1433.
47. Yang-Yen, H.-F., R. Chiu, and M. Karin. 1990. Elevation of AP1 activity during F9 cell differentiation is due to increased c-jun transcription. New Biol. 2:351.
48. Baldwin, A. S., Jr. 1996. The NF-κB and IκB proteins: new discoveries and insights. Annu. Rev. Immunol. 14:649.
49. Nakanishi, H., K. A. Brewer, and J. H. Exton. 1993. Activation of the ζ isoenzyme of protein kinase C by phosphatidylinositol 3,4,5-trisphosphate. J. Biol. Chem. 268:13.
50. Diaz-Meco, M. T., E. Berra, M. M. Municio, L. Sanz, J. Lozano. I. Dominguez. V. Diaz-Golpe, M. T. Lain de Lera, J. Alcami, C. V. Paya, F. Arenzana-Seisdedos, J.-L. Virelizier, and J. Moscat. 1993. A dominant negative protein kinase Cζ subspecies blocks NF-κB activation. Mol. Cell Biol. 13: 4770.
51. Rayhel, E. J., M. H. Dehoff, and V. M. Holers. 1991. Characterization of the human complement receptor 2 (CR2, CD21) promoter reveals sequence shared with regulatory regions of other developmentally restricted B cell proteins. J. Immunol. 146:2021.
52. Wilson, G. L., V. Najfeld, E. Kozlow, J. Minniger, D. Ward, and J. H. Kehrl. 1993. Genomic structure and chromosomal mapping of the human CD22 gene. J. Immunol. 150:5013.
53. Pleiman, C. M., S. D. Gimpel, L. S. Park, H. Harada, T. Taniguchi, and S. F. Ziegler. 1991. Organization of the murine and human interleukin-7 receptor genes: two mRNAs generated by differential splicing and presence of a type I-interferon inducible promoter. Mol. Cell. Biol. 11:3052.
54. Queen, C., and D. Baltimore. 1983. Immunoglobulin gene transcription is activated by downstream sequence elements. Cell 33:741.
55. Bergman, Y., D. Rice, R. Grosschedl, and D. Baltimore. 1984. Two regulatory elements for immunoglobulin κ light chain gene expression. Proc. Natl. Acad. Sci. USA 81:7041.
56. O'Brien, D. P., E. M. Oltz, and B. G. Van Ness. 1997. Coordinate transcription and V (D)J recombination of the immunoglobulin light-chain locus: NF-κB-dependent and -independent pathways of activation. Mol. Cell. Biol 17:3477.